• Reporting to the Senior Director, CMC Operations, the CMC Technical Manager, Peptide Development is responsible for the technical oversight of peptide programs at CDMO manufacturing sites and in-house R&D activities. • This role supports phase-appropriate development, disposition, and distribution of Perspective Therapeutics’ peptide-based radiopharmaceuticals across Phase I-III clinical and pre-commercial programs. • The individual will serve as a key technical lead for late-stage development and commercialization activities, ensuring compliance with GMP standards. • Responsible for overseeing all the peptide programs at CDMO and ensuring the activities are completed in a timely manner to support peptide based radiopharmaceutical drug candidates. • Responsible for review and approval of master batch records, method validation protocols and reports, test methods, specifications, etc. for early phase clinical, late phase clinical and commercial peptide products. • Manage the technical and quality aspects of clinical projects from raw materials to manufacturing to packaging, distribution and release/stability. • Perform ongoing review of batch records as part of product release, working closely with quality on deviations and CAPAs, and ensuring appropriate communication of issues, development and plans. • Work closely with QA and early Discovery organizations throughout the development and manufacturing processes. • Ensure all relevant SOPs are followed to support activities carried out at CDMOs. • Acting as SME when needed and in providing or reviewing responses to regulatory agency findings from inspections. • Draft and technical review of IND/IMPD CMC sections, briefing packages, and any other regulatory submissions.